Invention Grant
- Patent Title: Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
-
Application No.: US15973735Application Date: 2018-05-08
-
Publication No.: US10745473B2Publication Date: 2020-08-18
- Inventor: Matthew John Edwards , Jean-Michel Rene Rondeau , Danforth Miller , Daniel Huang , Hans-Peter Knopf , Gino Anselmus Van Heeke , Rene Hemmig , Kapil Gupta , Nicole Haubst , Barbara Andlauer
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Yichen Liu
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/395 ; A61K9/00 ; A61K45/06 ; A61K9/16 ; A61K39/00 ; A61P37/08 ; A61P11/06

Abstract:
The invention provides molecules, e.g., antibodies or antibody fragments, that specifically bind thymic stromal lymphopoietin (TSLP), compositions comprising these molecules, and methods of using and producing these molecules.
Public/Granted literature
- US20180327489A1 THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING MOLECULES AND METHODS OF USING THE MOLECULES Public/Granted day:2018-11-15
Information query